Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

First report of human immunodeficiency virus transmission via an RNA-screened blood donation.

Delwart EL, Kalmin ND, Jones TS, Ladd DJ, Foley B, Tobler LH, Tsui RC, Busch MP.

Vox Sang. 2004 Apr;86(3):171-7.

PMID:
15078251
2.

Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?

Busch MP.

Transfus Clin Biol. 2004 Feb;11(1):26-32. Review.

PMID:
14980546
3.

Yield and future issues of nucleic acid testing.

Roth WK, Seifried E.

Transfus Clin Biol. 2001 Jun;8(3):282-4. Review.

PMID:
11499978
4.

[Screening for viral genomes in blood transfusion].

Coste J.

Transfus Clin Biol. 2000 Jun;7 Suppl 1:11s-17s. Review. French.

PMID:
10919218
5.

Tissue donation and virus safety: more nucleic acid amplification testing is needed.

Pruss A, Caspari G, Krüger DH, Blümel J, Nübling CM, Gürtler L, Gerlich WH.

Transpl Infect Dis. 2010 Oct;12(5):375-86. doi: 10.1111/j.1399-3062.2010.00505.x. Review.

PMID:
20412535
6.
7.

Genomic screening for blood-borne viruses in transfusion settings.

Allain JP.

Clin Lab Haematol. 2000 Feb;22(1):1-10. Review.

PMID:
10762297
8.

HIV and blood transfusions: focus on seroconversion.

Busch MP.

Vox Sang. 1994;67 Suppl 3:13-8. Review. No abstract available.

PMID:
7975476
9.

Screening of HIV infection: role of molecular and immunological assays.

Weber B.

Expert Rev Mol Diagn. 2006 May;6(3):399-411. Review.

PMID:
16706742
10.

US NAT yield: where are we after 2 years?

Stramer SL.

Transfus Med. 2002 Aug;12(4):243-53. Review.

PMID:
12220253
11.

Nucleic acid testing: update and applications.

Benjamin RJ.

Semin Hematol. 2001 Oct;38(4 Suppl 9):11-6. Review.

PMID:
11685721
12.

[Viruses and unconventional transmissible agents: update on transmission via blood ].

Barin F.

Transfus Clin Biol. 2000 Jun;7 Suppl 1:5s-10s. Review. French.

PMID:
10919217
13.

Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century.

Dwyre DM, Fernando LP, Holland PV.

Vox Sang. 2011 Jan;100(1):92-8. doi: 10.1111/j.1423-0410.2010.01426.x. Review.

PMID:
21175659
14.

Hepatitis B virus blood screening: unfinished agendas.

Comanor L, Holland P.

Vox Sang. 2006 Jul;91(1):1-12. Review. Erratum in: Vox Sang. 2007 Apr;92(3):278.

PMID:
16756595
15.

[Controlled viral risks].

Barin F.

Transfus Clin Biol. 2000 Feb;7(1):24-9. Review. French.

PMID:
10730343
16.

Transfusion risks of yesterday and of today.

Allain JP.

Transfus Clin Biol. 2003 Feb;10(1):1-5. Review.

PMID:
12668180
18.

NAT screening of blood and plasma donations: evolution of technology and regulatory policy.

Tabor E, Epstein JS.

Transfusion. 2002 Sep;42(9):1230-7. Review. No abstract available.

PMID:
12430684
19.

NAT and viral safety in blood transfusion.

Roth WK, Buhr S, Drosten C, Seifried E.

Vox Sang. 2000;78 Suppl 2:257-9. Review.

PMID:
10938964
20.

Hepatitis C virus and blood transfusion: past and present risks.

van der Poel CL.

J Hepatol. 1999;31 Suppl 1:101-6. Review.

PMID:
10622570
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk